EU-Startups
Spain’s Adaptam Therapeutics secures €3 million to target immune cells that help tumours evade treatment
Adaptam Therapeutics, a San Sebastian-based company pioneering cancer immunotherapies specifically targeting immunosuppressive myeloid cells, today announces the successful completion of a €3 million pre-Seed financing round […]
